Genomic newborn screening: ICoNS
Gene: ALDH7A1
Well established gene disease association
ClinGen: strong actionability in paediatric patients
Summary: classic presentation neonatal onset seizures which respond to pyridoxine but are not well controlled with antiepileptics. Later onset of seizures has been reported.
Despite seizure control most patients have developmental delay/Intellectual disability
Non genetic confirmatory tests: alpha-aminoadipic semialdehyde (α-AASA) in urine and/or plasma (elevated)
Pipecolic acid
Δ1-piperideine-6-carboxylate (Δ1-P6C)
Intervention: Pyridoxine for seizure control.
From consensus guideline: To improve outcome, a lysine-restricted diet and competitive inhibition of lysine transport through the use of pharmacologic doses of arginine have been recommended as an adjunct therapy
Additional information
Incidence: 1:65 000 to 1:250 000 live births
Onset of seizures can be outside the neonatal period
Consensus guideline: PMID: 33200442
Included in:
Sources: OtherCreated: 27 Jun 2025, 2:26 p.m. | Last Modified: 27 Jun 2025, 2:36 p.m.
Panel Version: 0.4
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Epilepsy, early-onset, 4, vitamin B6-dependent
Publications
gene: ALDH7A1 was added gene: ALDH7A1 was added to Genomic newborn screening: ICoNS. Sources: Other Mode of inheritance for gene: ALDH7A1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ALDH7A1 were set to PMID: 20301659; 33200442 Phenotypes for gene: ALDH7A1 were set to Epilepsy, early-onset, 4, vitamin B6-dependent Penetrance for gene: ALDH7A1 were set to Complete Review for gene: ALDH7A1 was set to GREEN